Logo

Decode s Encode, Vertex Pen Pharmacogenomics Partnership

Jan 31, 2003

NEW YORK, Jan. 31 - A Decode subsidiary will collect and analyze pharmacogenomics data for a clinical study performed by Vertex Pharmaceuticals.

 

The agreement with the unit, Encode, aims at providing Vertex with pharmacogenomics data on therapeutics responses in patients treated with Vertex drug candidate for psoriasis, the companies said.

 

The deal also may lead the partners to design pharmacogenomics tests, in which event the companies would develop and commercialize.

 

Click here for more information.

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.